Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Bacterial Infections and Mycoses

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 303 articles: HTML format

Single Articles

November 2025
1. KWAGHE VG, Erameh C, Courtney LP, Samuels JO, et al
   Epidemiology and Clinical Characteristics of Human Rickettsial Infections Detected in Nigeria: Discovery of a Significant Contributor to Acute Febrile Illness.
   Clin Infect Dis. 2025;81.
   PubMed     Abstract available
   
   
   
2. MURRILL MT, Velasquez GE, Szumowski JD, Phillips A, et al
   Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
   Clin Infect Dis. 2025 Nov 19:ciaf628. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. DESIMONE DC, Baddour LM
   Post Treatment Blood Cultures in Patients with Infective Endocarditis: Valuable, Inconsequential or Worse?
   Clin Infect Dis. 2025 Nov 12:ciaf618. doi: 10.1093.
   PubMed    
   
   
   
4. REGINA J, Ianculescu N, Tzimas G, Monney P, et al
   Rethinking the routine: Are repeat blood cultures necessary after completion of infective endocarditis treatment?
   Clin Infect Dis. 2025 Nov 12:ciaf617. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. GEORGE CM, Sanvura P, Namunesha A, Bisimwa JC, et al
   Epidemiology of Vibrio cholerae Infections in the Households of Cholera Patients in the Democratic Republic of the Congo: PICHA7 WASHmobile Prospective Cohort Study.
   Clin Infect Dis. 2025;81:797-805.
   PubMed     Abstract available
   
   
   
6. GEORGE CM, Sanvura P, Bisimwa JC, Endres K, et al
   Effects of a Water, Sanitation, and Hygiene Program on Diarrhea, Cholera, and Child Growth in the Democratic Republic of the Congo: A Cluster-Randomized Controlled Trial of the Preventative Intervention for Cholera for 7 Days (PICHA7 WASHmobile) Mobil
   Clin Infect Dis. 2025;81:785-796.
   PubMed     Abstract available
   
   
   
7. MACVANE SH, Moon R, David J, Rosenthal N, et al
   Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals.
   Clin Infect Dis. 2025;81:710-720.
   PubMed     Abstract available
   
   
   October 2025
8. POUY R, Rallet B, Coutureau C, Hentzien M, et al
   Towards a wider use of oral antibiotic switch in infective endocarditis.
   Clin Infect Dis. 2025 Oct 30:ciaf599. doi: 10.1093.
   PubMed    
   
   
   
9. SUZUKI J, Mizuno T, Takahashi S, Imai H, et al
   Does oral antibiotic switching therapy show similar efficacy to intravenous administration for treating infective endocarditis?
   Clin Infect Dis. 2025 Oct 30:ciaf598. doi: 10.1093.
   PubMed    
   
   
   
10. LOVEDAY M, Hughes J, Mchunu N, Yende-Zuma N, et al
    Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2025 Oct 29:ciaf593. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. WIJK M, Denti P, Gausi K, Myers B, et al
    Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment.
    Clin Infect Dis. 2025 Oct 24:ciaf586. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. MINGCHAY P, Kawkitinarong K, Torvorapanit P, Ohata PJ, et al
    Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial).
    Clin Infect Dis. 2025 Oct 23:ciaf580. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. LI HK, Zhu N, Waddell O, Coelho J, et al
    Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales.
    Clin Infect Dis. 2025 Oct 16:ciaf492. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. MOONAN PK, Buff A, Nandakumar S, Morris Bamrah S, et al
    C-reactive protein in TB meningitis: signal, surrogate, or saboteur?
    Clin Infect Dis. 2025 Oct 16:ciaf575. doi: 10.1093.
    PubMed    
    
    
    
15. TUGUME L, Cresswell FV, Bahr NC, Dai B, et al
    C-reactive protein in TB meningitis: a viable biomarker for individualized care.
    Clin Infect Dis. 2025 Oct 16:ciaf576. doi: 10.1093.
    PubMed    
    
    
    
16. MULENGA H, Shenje J, Mendelsohn SC, Luabeya AKK, et al
    Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis.
    Clin Infect Dis. 2025 Oct 15:ciaf562. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. CHEN SC, Lee YT
    Precision Prevention of Tuberculosis in Biologic Therapy: Lessons Beyond Screening Strategies.
    Clin Infect Dis. 2025 Oct 3:ciaf559. doi: 10.1093.
    PubMed    
    
    
    
18. SAUNDERS KE, Charles A, Doyle TJ, Reyes J, et al
    Risk factors associated with progression to clinical Candida auris infection among adults with previous colonization-Florida, 2019-2023.
    Clin Infect Dis. 2025 Oct 2:ciaf551. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2025
19. RUIZ-TAGLE C, Seguel R, Villarroel L, Bernales M, et al
    Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.
    Clin Infect Dis. 2025 Sep 26:ciaf526. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. CHEN SC, Chen CC
    Reassessing Adherence Trajectories in Multidrug-Resistant Tuberculosis: Recovery Advantage and Hidden Biases.
    Clin Infect Dis. 2025 Sep 25:ciaf536. doi: 10.1093.
    PubMed    
    
    
    
21. BROOKS MB, Lecca L, Becerra MC, Calderon RI, et al
    The Role of Youths in Within-Household Tuberculosis Transmission: A Household Contact Cohort Study.
    Clin Infect Dis. 2025 Sep 24:ciaf490. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. WALLS G, McGrath L, Herdman MT, Campbell AJ, et al
    Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study.
    Clin Infect Dis. 2025 Sep 24:ciaf522. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. OLESEN RH, Larsen EB, Rubak T, Baunwall SMD, et al
    Cost-Effectiveness of Hospital-at-Home and Fecal Microbiota Transplantation in Treating Older Patients With Clostridioides difficile.
    Clin Infect Dis. 2025;81:348-354.
    PubMed     Abstract available
    
    
    
24. LEE G, Hollingsworth BD, Giandomenico DA, Fisher TG, et al
    Impact of Revised Diagnostic Testing Algorithms and Case Definitions on Lyme Disease Surveillance in a Low-Incidence State: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2025;81:403-406.
    PubMed     Abstract available
    
    
    
25. PEREZ-RECIO S, Grijota-Camino MD, Guardiola J, Juanola X, et al
    Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years' Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country.
    Clin Infect Dis. 2025 Sep 5:ciaf491. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. ARRIAGA MB, Amorim G, Figueiredo MC, Staats C, et al
    Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts.
    Clin Infect Dis. 2025 Sep 3:ciaf475. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. SEIBERT AM, Matheu M, Buckel WR, Bledsoe J, et al
    Increasing HIV Testing During Gonorrhea and Chlamydia Evaluations in Urgent Care and Emergency Departments: A Large Health System Initiative.
    Clin Infect Dis. 2025 Sep 1:ciaf434. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
28. LAW S, Fulcher I, Ashraf S, Bastard M, et al
    Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.
    Clin Infect Dis. 2025 Aug 22:ciaf467. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. POORE H, Wambi P, Nkereuwem E, Nakafeero J, et al
    The three-gene Xpert Host Response signature for pediatric tuberculosis screening: A prospective diagnostic accuracy study.
    Clin Infect Dis. 2025 Aug 21:ciaf445. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. SINHA P, Bhargava M, Dauphinais MR, Carwile ME, et al
    In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study.
    Clin Infect Dis. 2025 Aug 20:ciaf400. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. RALLET B, Pouy R, Coutureau C, Blot M, et al
    Should we extend the use of oral antibiotics in infective endocarditis? The ENDO-ORAL study.
    Clin Infect Dis. 2025 Aug 18:ciaf452. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. BISIMWA BC, Kiselinova M, Cuella I, Rigouts L, et al
    Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting.
    Clin Infect Dis. 2025 Aug 12:ciaf451. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. KHALIL S, Sohail MR
    Timing is Everything: Integrating Time to Blood Culture Positivity in Predicting Risk of Endocarditis in Patients with Staphylococcus aureus Bacteremia.
    Clin Infect Dis. 2025 Aug 12:ciaf447. doi: 10.1093.
    PubMed    
    
    
    
34. RUTAKINGIRWA MK, Skipper CP, Dai B, Wele A, et al
    Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.
    Clin Infect Dis. 2025 Aug 7:ciaf432. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. CHURCHYARD GJ, Swindells S, Gupta A, Shah NS, et al
    Preventing multidrug resistant tuberculosis: the dawn of a new era.
    Clin Infect Dis. 2025 Aug 7:ciaf426. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. SUTTON KN, Lydon E, Rader A, Barton KD, et al
    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections.
    Clin Infect Dis. 2025;81.
    PubMed     Abstract available
    
    
    
37. RUFFIN F, Sutton KN, Miller J, Lane H, et al
    A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection.
    Clin Infect Dis. 2025;81.
    PubMed     Abstract available
    
    
    
38. KRAH NM, Fai C, Sutton KN, Rader A, et al
    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia.
    Clin Infect Dis. 2025;81.
    PubMed     Abstract available
    
    
    
39. HOWARD-ANDERSON J, Doernberg SB, Dixon D, Gopinath R, et al
    Interagency Collaboration for Patient-Centered Antibacterial Drug Development.
    Clin Infect Dis. 2025;81.
    PubMed     Abstract available
    
    
    
40. YAN M, Hernandez A, Chan KK, Stanbrook MB, et al
    Population-Based Analysis of the Risk of Mycobacterial Infections Associated With Immune Checkpoint Inhibitors.
    Clin Infect Dis. 2025;81:176-178.
    PubMed     Abstract available
    
    
    
41. CHELI S, Torre A, Schiuma M, Montrasio C, et al
    NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.
    Clin Infect Dis. 2025;81:145-152.
    PubMed     Abstract available
    
    
    July 2025
42. MURRAY MB, Madden AE, Ofori SK
    Harmonization of Study Design and Reporting for Chronic Pulmonary Aspergillosis in Tuberculosis Patients.
    Clin Infect Dis. 2025 Jul 30:ciaf309. doi: 10.1093.
    PubMed    
    
    
    
43. BEZUIDENHOUT C, Long L, Nichols B, Meyer-Rath G, et al
    Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysis.
    Clin Infect Dis. 2025 Jul 24:ciaf389. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. SMITH DJ, Misas E, Gold JAW, Evert N, et al
    Fungal meningitis in U.S. Patients who Received Epidural Anesthesia in Matamoros, Mexico.
    Clin Infect Dis. 2025 Jul 22:ciaf399. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. LIU W, He T, Zhan S, Qin H, et al
    Safety, feasibility and rifapentine plasma concentration in Chinese children with 1 month of daily rifapentine plus isoniazid for tuberculosis infection.
    Clin Infect Dis. 2025 Jul 21:ciaf404. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. ROCKMAN L, Abdulgader SM, Minnies S, Palmer Z, et al
    Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputum.
    Clin Infect Dis. 2025 Jul 18:ciaf397. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. ANDREWS JR, Kendall EA, Cattamanchi A, Denkinger CM, et al
    Projecting the impact and costs of near point-of-care tuberculosis screening assays in community-based active case finding.
    Clin Infect Dis. 2025 Jul 17:ciaf395. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. ESCRIHUELA-VIDAL F, Ong SWX, Oriol I, Grillo S, et al
    Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post-hoc Analysis of Individual Participant Data from Two Randomized Trials.
    Clin Infect Dis. 2025 Jul 16:ciaf387. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. LOPEZ LF, Arenas S, Jimenez A, Ferreira TBD, et al
    Improved consistency of Candida auris colonization screening with an anterior nares and hands composite sample.
    Clin Infect Dis. 2025 Jul 10:ciaf365. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. WANG B, Giles L, Andraweera P, McMillan M, et al
    Long-term protection against invasive meningococcal B disease and gonococcal infection five years after implementation of funded childhood and adolescent 4CMenB vaccination program in South Australia: an observational cohort and case-control study.
    Clin Infect Dis. 2025 Jul 10:ciaf372. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. MACLEAN EL, Pham YN, Pham CD, Nguyen BC, et al
    Long-term outcomes among people with multi-drug resistant tuberculosis in Vietnam: a prospective cohort study.
    Clin Infect Dis. 2025 Jul 9:ciaf363. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. LI Y, Zhang Y, Song L, Cai C, et al
    A Short, All-Oral Regimen for Pre-Extensively Drug-Resistant Tuberculosis: A Multicenter Open-label Single-arm Study.
    Clin Infect Dis. 2025 Jul 8:ciaf351. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. COX SR, Moe AH, Gupte AN, Kadam A, et al
    A point-of-care prediction tool for recurrent tuberculosis.
    Clin Infect Dis. 2025 Jul 8:ciaf353. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. SANTOS-PATARROYO SD, Saleh OA, Chesdachai S, Lahr BD, et al
    Blood Culture Time to Positivity and Risk of Infective Endocarditis.
    Clin Infect Dis. 2025 Jul 4:ciaf359. doi: 10.1093.
    PubMed    
    
    
    
55. STROMDAHL M, Ursing J
    Time to positivity in Staphylococcus aureus bacteremia - one of many pieces in the diagnostic puzzle.
    Clin Infect Dis. 2025 Jul 4:ciaf360. doi: 10.1093.
    PubMed    
    
    
    
56. TONIZZO A, Munoz P, Burillo A, Adan I, et al
    Is Time to Positivity in Staphylococcus aureus Bacteremia a Harbinger of Endocarditis?
    Clin Infect Dis. 2025 Jul 4:ciaf358. doi: 10.1093.
    PubMed    
    
    
    June 2025
57. TUGUME L, Cresswell FV, Engen NW, Tukundane A, et al
    Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study.
    Clin Infect Dis. 2025 Jun 24:ciaf261. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. MOYO M, Jarvis JN
    ART Management in Cryptococcal Meningitis.
    Clin Infect Dis. 2025 Jun 24:ciaf227. doi: 10.1093.
    PubMed    
    
    
    
59. PATAMATAMKUL S
    Should ART Be Interrupted in Recently Initiated Persons With Recently Diagnosed HIV-Associated Cryptococcal Meningitis?
    Clin Infect Dis. 2025 Jun 24:ciaf226. doi: 10.1093.
    PubMed    
    
    
    
60. BUSSINI L, Bavaro DF, Brunetta E, Carella F, et al
    What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections?
    Clin Infect Dis. 2025 Jun 18:ciaf323. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. PAPADIMITRIOU-OLIVGERIS M, Guery B
    Redefining complicated coagulase negative staphylococcal bacteremia.
    Clin Infect Dis. 2025 Jun 18:ciaf308. doi: 10.1093.
    PubMed    
    
    
    
62. VARISCO B, Rodriguez-Bano J, Lopez-Cortes LE
    Toward defining complicated coagulase-negative staphylococcal bacteremia.
    Clin Infect Dis. 2025 Jun 18:ciaf307. doi: 10.1093.
    PubMed    
    
    
    
63. LU X, Jiang Y, Zhang R, Zhang Y, et al
    Epidemiologic and Bacterial Factors Facilitating Long-Term Transmission of Multidrug-Resistant Tuberculosis in Shanghai, China.
    Clin Infect Dis. 2025 Jun 18:ciaf313. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. AGARWAL R, Nyendak M, Chava N, Allam RR, et al
    Long-term protection from TB preventive treatment among people with HIV in a high-burden tuberculosis setting: an observational cohort study from India.
    Clin Infect Dis. 2025 Jun 16:ciaf322. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. SHAPIRO L, Henao-Martinez AF
    Letter to the Editor: Re-evaluating Immune-Based Strategies for Cryptococcal Meningitis in Non-HIV Populations.
    Clin Infect Dis. 2025 Jun 16:ciaf326. doi: 10.1093.
    PubMed    
    
    
    
66. KURLAND S, Furebring M, Lowdin E, Olaison L, et al
    Antifungal therapy in Candida infective endocarditis: a comparison of echinocandins and other treatment regimens in a nation-wide cohort study.
    Clin Infect Dis. 2025 Jun 14:ciaf312. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. REDMOND SN, Cadnum JL, Jencson AL, Kaple CE, et al
    Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital.
    Clin Infect Dis. 2025;80:984-991.
    PubMed     Abstract available
    
    
    
68. BAGHDADI JD, Goodman KE, Magder LS, Claeys KC, et al
    Association Between Delayed Broad-Spectrum Gram-negative Antibiotics and Clinical Outcomes: How Much Does Getting It Right With Empiric Antibiotics Matter?
    Clin Infect Dis. 2025;80:949-958.
    PubMed     Abstract available
    
    
    
69. TURNER NA, Grambow SC, Polage C, Kuhar DT, et al
    Natural History of Clostridioides difficile-Related Disease Progression in the 2-Step Testing Era.
    Clin Infect Dis. 2025;80:975-983.
    PubMed     Abstract available
    
    
    
70. LIEU A, Zimmet AN, Pozdol J, Kushner LE, et al
    Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease.
    Clin Infect Dis. 2025;80:1095-1102.
    PubMed     Abstract available
    
    
    
71. GALANIS E, MacDougall L, Rose C, Chen SCA, et al
    Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study.
    Clin Infect Dis. 2025;80:1088-1094.
    PubMed     Abstract available
    
    
    
72. JAGANATH D, Nabeta P, Nicol MP, Castro R, et al
    Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study.
    Clin Infect Dis. 2025 Jun 3:ciaf289. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. DE JAGER V, Mockeliunas L, You H, Simonsson USH, et al
    A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis.
    Clin Infect Dis. 2025 Jun 2:ciaf276. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
74. PURCHASE SE, Brigden J, Seddon JA, Martinson NA, et al
    Risk of tuberculosis infection in young children exposed to multidrug-resistant tuberculosis in the TB-CHAMP multi-site randomised controlled trial.
    Clin Infect Dis. 2025 May 29:ciaf284. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. BONGOMIN F, Denning DW
    Pulmonary Tuberculosis Associated Chronic Pulmonary Aspergillosis: Urgent Need to Standardize Reporting of Prevalence Studies.
    Clin Infect Dis. 2025 May 28:ciaf279. doi: 10.1093.
    PubMed    
    
    
    
76. 
    Correction to: Serial Mass Screening for Tuberculosis Among Incarcerated Persons in Brazil.
    Clin Infect Dis. 2025 May 21:ciaf223. doi: 10.1093.
    PubMed    
    
    
    
77. REGAN JJ, Wang Z, Phares CR
    The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?
    Clin Infect Dis. 2025 May 15:ciaf129. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. BROWN KA, Fridman DJ, Garber GE, Johnstone J, et al
    The Burden of Antimicrobial Resistant Bacteremia in Ontario: A Population-wide Analysis of Attributable Mortality from 110 Pathogen-Antibiotic Combinations.
    Clin Infect Dis. 2025 May 13:ciaf213. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al
    Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. CHIANG SS, Campbell JR, Pelissari DM, de Oliveira MCB, et al
    The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016-2022.
    Clin Infect Dis. 2025 May 6:ciaf233. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
81. YETMAR ZA, Marty PK, Clement J, Miranda C, et al
    State-of-the-Art Review: Modern Approach to Nocardiosis-Diagnosis, Management, and Uncertainties.
    Clin Infect Dis. 2025;80:e53-e64.
    PubMed     Abstract available
    
    
    
82. MANOHARAN-BASIL S, Vanbaelen T, Kenyon C
    Evidence for selection of doxycycline resistance in Staphylococcus aureus in DoxyPrEP study.
    Clin Infect Dis. 2025 Apr 30:ciaf219. doi: 10.1093.
    PubMed    
    
    
    
83. MARKLEY JD, Bajaj JS
    Rethinking Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Patients With Cirrhosis: First, Do No Harm.
    Clin Infect Dis. 2025;80:710-714.
    PubMed     Abstract available
    
    
    
84. LANGFORD BJ, Brown KA, Lau C, Calzavara A, et al
    Evaluating Harms Associated With Prolonged Antibiotic Duration of Therapy in Community-Dwelling Older Adults: A Cohort Study Using Instrumental Variable Analysis.
    Clin Infect Dis. 2025;80:715-722.
    PubMed     Abstract available
    
    
    
85. ALLEN C, Deanehan JK, Dotan Y, Eisenberg MA, et al
    Development of a Reference Standard to Assign Bacterial Versus Viral Infection Etiology Using an All-inclusive Methodology for Comparison of Novel Diagnostic Tool Performance.
    Clin Infect Dis. 2025;80:735-743.
    PubMed     Abstract available
    
    
    
86. LI C, Zhu DP, Chen J, Zhu XY, et al
    Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0).
    Clin Infect Dis. 2025;80:807-816.
    PubMed     Abstract available
    
    
    
87. PAPADIMITRIOU-OLIVGERIS M, Ledergerber B, Siedentop B, Monney P, et al
    Beyond the Timeline: 1-Year Mortality Trends in Early Versus Late Prosthetic Valve Endocarditis.
    Clin Infect Dis. 2025;80:804-806.
    PubMed     Abstract available
    
    
    
88. LARSSON L, Calderwood CJ, Marambire ET, Held K, et al
    Body mass index trajectories and association with tuberculosis risk in a cohort of household contacts in Southern Africa.
    Clin Infect Dis. 2025 Apr 28:ciaf222. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. DAHL VN, Pedersen OS, Butova T, Kuzhko M, et al
    Effectiveness of the BPaL(M) Regimen for Drug-Resistant Tuberculosis in Ukraine under Programmatic Conditions.
    Clin Infect Dis. 2025 Apr 25:ciaf214. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. YOON H, Pirofski LA, Boulware DR
    Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies.
    Clin Infect Dis. 2025 Apr 25:ciaf218. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. BIRABAHARAN M
    Vancomycin-Resistant Enterococci-Active Perioperative Prophylaxis for Liver Transplant Patients Requires Attention to the Gut Microbiota.
    Clin Infect Dis. 2025 Apr 22:ciaf168. doi: 10.1093.
    PubMed    
    
    
    
92. KIM S, Pelissari DM, Harada LO, Sanchez M, et al
    Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
    Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. SUTHERLAND JS, van der Spuy GD, Shaw JA, Richardson T, et al
    Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study.
    Clin Infect Dis. 2025 Apr 16:ciaf105. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. CHESDACHAI S, DeSimone DC, Ranganath N, Abu Saleh OM, et al
    Plasma Quantitative Microbial Cell-Free DNA for Staphylococcal Cardiac Implantable Electronic Device Infection - Too Soon?
    Clin Infect Dis. 2025 Apr 15:ciaf195. doi: 10.1093.
    PubMed    
    
    
    
95. KARCHMER AW, Park SY, Zimetbaum PJ
    Diagnosing Staphylococcal Cardiac Electronic Implantable Device Endocarditis: The Potential of Quantitative Plasma Cell-Free Microbial DNA.
    Clin Infect Dis. 2025 Apr 15:ciaf196. doi: 10.1093.
    PubMed    
    
    
    
96. HODGES MR, Tawadrous M, Cornely OA, Thompson GR 3rd, et al
    Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS).
    Clin Infect Dis. 2025 Apr 9:ciaf185. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. 
    Correction to: Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
    Clin Infect Dis. 2025 Apr 4:ciaf174. doi: 10.1093.
    PubMed    
    
    
    
98. GOEHRINGER F, Soudant M, Alauzet C, Selton-Suty C, et al
    Single- versus multiple-sampling strategy for blood cultures in the diagnosis of infective endocarditis: the prospective multicenter UniEndo study.
    Clin Infect Dis. 2025 Apr 3:ciaf163. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. STEAD D, Wasserman S, Steenkamp E, Parrish A, et al
    Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With Human Immunodeficiency Virus in East London, South Africa.
    Clin Infect Dis. 2025 Apr 2:ciaf080. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2025
100. BARTL L, Zeeb M, Kalin M, Loosli T, et al
     Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical Data.
     Clin Infect Dis. 2025 Mar 25:ciaf149. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. ADZEMOVIC T, Nalintya E, Fieberg A, Mande E, et al
     Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV Disease.
     Clin Infect Dis. 2025 Mar 25:ciaf079. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. PRODANUK M, Silverberg SL, Piche-Renaud PP, Farrar DS, et al
     Adverse events of first-line therapy for pediatric tuberculosis: A systematic review and meta-analysis.
     Clin Infect Dis. 2025 Mar 24:ciaf152. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. CUELLA-MARTIN I, Hakizayezu F, Ahmed A, Runyambo D, et al
     Paucibacillary tuberculosis drives the low positive predictive value of Xpert MTB/RIF Ultra for rifampicin resistance detection in low-prevalence settings.
     Clin Infect Dis. 2025 Mar 22:ciaf132. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. MADDEN A, Ofori SK, Budu M, Sisay E, et al
     A systematic review of chronic pulmonary aspergillosis among patients treated for pulmonary tuberculosis.
     Clin Infect Dis. 2025 Mar 21:ciaf150. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. BRUNEL AS, Seydoux C, Schmidt S, Ahlyege S, et al
     Epidemiology, Risk Factors and Outcome of Neutropenic Enterocolitis in Onco-Hematological Patients according to Chemotherapy Regimen.
     Clin Infect Dis. 2025 Mar 20:ciaf134. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. SODEKE O, Shah NS, Pals S, Riabokon S, et al
     Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.
     Clin Infect Dis. 2025 Mar 18:ciaf069. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. TALA-IGHIL T, Garcia-Hermoso D, Dalle F, Cassaing S, et al
     Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012-2022).
     Clin Infect Dis. 2025;80:529-539.
     PubMed     Abstract available
     
     
     
108. KIM JY, Hwang H, Yim D, Choi Y, et al
     Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary Disease.
     Clin Infect Dis. 2025;80:637-643.
     PubMed     Abstract available
     
     
     
109. BURASTERO GJ, Wey EQ, Guidetti V, Cantergiani S, et al
     Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci.
     Clin Infect Dis. 2025 Mar 14:ciaf121. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. SINGLA R, Khan S, Silsarma A, Chavan V, et al
     Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
     Clin Infect Dis. 2025 Mar 13:ciaf068. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. PAPADIMITRIOU-OLIVGERIS M, Senn L, Guery B
     Validation of the proposed definition for complicated coagulase negative staphylococcal bacteremia.
     Clin Infect Dis. 2025 Mar 13:ciaf119. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. KARCHMER AW, Kaufman NJ, Park SY, Modi RM, et al
     Quantitative Microbial Cell-Free DNA Sequencing from Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices.
     Clin Infect Dis. 2025 Mar 11:ciaf113. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2025
113. SOGE OO, Thibault CS, Cannon CA, McLaughlin SE, et al
     Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria gonorrhoeae and Colonization with Tetracycline-Resistant Staphylococcus aureus and Group A Streptococcus.
     Clin Infect Dis. 2025 Feb 28:ciaf089. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. NGUYEN MH, Daley CL
     Chronic Pulmonary Aspergillosis and Nontuberculous Mycobacterial Pulmonary Disease: Two Peas in a Pod.
     Clin Infect Dis. 2025 Feb 28:ciaf091. doi: 10.1093.
     PubMed    
     
     
     
115. DENNING DW, Kosmidis C
     Chronic pulmonary aspergillosis is a differential diagnosis and co-infection with Nontuberculous Mycobacterial Pulmonary Disease.
     Clin Infect Dis. 2025 Feb 28:ciaf090. doi: 10.1093.
     PubMed    
     
     
     
116. JASWAL MR, Martinez L, Brooks M, Farooq S, et al
     Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan.
     Clin Infect Dis. 2025 Feb 27:ciaf088. doi: 10.1093.
     PubMed     Abstract available
     
     
     
117. STEFANOVIC A, Alam ME, Matic N, Larnder A, et al
     Increased Severity of Multidrug-Resistant Shigella sonnei Infections in People Experiencing Homelessness.
     Clin Infect Dis. 2025;80:339-346.
     PubMed     Abstract available
     
     
     
118. HENNESSEE I, Palmer S, Reik R, Miles-Jay A, et al
     Epidemiological and Clinical Features of a Large Blastomycosis Outbreak at a Paper Mill in Michigan.
     Clin Infect Dis. 2025;80:356-363.
     PubMed     Abstract available
     
     
     
119. HAGMAN K, Nilsson AC, Hedenstierna M, Ursing J, et al
     Outcomes of Adjunctive Corticosteroid Treatment in Hypoxemic Adults Hospitalized for Mycoplasma pneumoniae Pneumonia: A Retrospective Cohort Study.
     Clin Infect Dis. 2025;80:454-460.
     PubMed     Abstract available
     
     
     
120. HENNESSEE I, Benedict K, Bahr NC, Lipner SR, et al
     Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid Arthritis.
     Clin Infect Dis. 2025;80:364-366.
     PubMed     Abstract available
     
     
     
121. GARCIA R, Septimus EJ, LeDonne J, Sturm LK, et al
     Prevention of Vascular Access Device-Associated Hospital-Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.
     Clin Infect Dis. 2025;80:444-450.
     PubMed     Abstract available
     
     
     
122. HSU AJ, Chiotos K, Heil EL, Shields RK, et al
     The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis.
     Clin Infect Dis. 2025 Feb 20:ciaf071. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. TZELIOS CA, Malatesta S, Carney T, White LF, et al
     Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.
     Clin Infect Dis. 2025 Feb 20:ciae642. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. SINHA A, Klebe R, Rekart ML, Alvarez JL, et al
     The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
     Clin Infect Dis. 2025 Feb 18:ciaf035. doi: 10.1093.
     PubMed     Abstract available
     
     
     
125. MUNSIFF SS
     American Thoracic Society/Centers for Disease Control and Prevention/European Respiratory Society/Infectious Diseases Society of America (ATS/CDC/ERS/IDSA) Updated guideline on the treatment of tuberculosis.
     Clin Infect Dis. 2025 Feb 14:ciaf066. doi: 10.1093.
     PubMed    
     
     
     
126. DREKONJA DM, Shaukat A, Huang Y, Zhang JH, et al
     A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection.
     Clin Infect Dis. 2025;80:52-60.
     PubMed     Abstract available
     
     
     
127. ALSHANNAQ AF, Kates AE, Keating JA, Mckinley LL, et al
     Diverse Sources and Latent Reservoirs of Community-Associated Clostridioides difficile Infection.
     Clin Infect Dis. 2025;80:37-42.
     PubMed     Abstract available
     
     
     
128. FEUERSTADT P, Chopra T, Knapple W, Van Hise NW, et al
     PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.
     Clin Infect Dis. 2025;80:43-51.
     PubMed     Abstract available
     
     
     
129. SHAH S, Kline EG, Haidar G, Squires KM, et al
     Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia.
     Clin Infect Dis. 2025;80:24-28.
     PubMed     Abstract available
     
     
     January 2025
130. MARANCHICK N, Peloquin CA, Haley CA
     Linezolid Dosing and Pharmacokinetics in North American Patients with Tuberculosis.
     Clin Infect Dis. 2025 Jan 21:ciaf027. doi: 10.1093.
     PubMed     Abstract available
     
     
     
131. VENA A, Tiseo G, Falcone M, Bartalucci C, et al
     Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study.
     Clin Infect Dis. 2025 Jan 15:ciae603. doi: 10.1093.
     PubMed     Abstract available
     
     
     
132. MOYO M, Lawrence DS, Jafali J, Molloy SF, et al
     Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in Human Immunodeficiency Virus-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.
     Clin Infect Dis. 2025 Jan 15:ciae586. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. ESPINOSA-PEREIRO J, Aguiar A, Nara E, Medina A, et al
     Safety, Efficacy and Pharmacokinetics of daily optimised doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis.
     Clin Infect Dis. 2025 Jan 10:ciaf003. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. ARBIV OA, Holmes T, Kim MJ, Yan M, et al
     Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis.
     Clin Infect Dis. 2025 Jan 9:ciaf004. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2024
135. NOLAN T, Bhusal C, Hoberman A, Llapur CJ, et al
     Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults who had Previously Received a Meningococcal ACWY Vaccine: Phase 3, Randomized, Controlled Clinical Study.
     Clin Infect Dis. 2024 Dec 26:ciae622. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. PLOTKIN SA, Shapiro ED
     The Current and Future State of Vaccines for Lyme Disease.
     Clin Infect Dis. 2024 Dec 23:ciae639. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. STROMDAHL M, Hagman K, Hedman K, Westman A, et al
     Time to Staphylococcus aureus Blood Culture Positivity as a risk marker of Infective Endocarditis: A Retrospective Cohort Study.
     Clin Infect Dis. 2024 Dec 21:ciae628. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. HATZL S, Geiger C, Kriegl L, Scholz L, et al
     Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis.
     Clin Infect Dis. 2024 Dec 20:ciae633. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. MACPHERSON L, Kik SV, Quartagno M, Lakay F, et al
     Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts.
     Clin Infect Dis. 2024 Dec 18:ciae528. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. COUSSEMENT J, Heath CH, Roberts MB, Lane RJ, et al
     Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand.
     Clin Infect Dis. 2024 Dec 18:ciae630. doi: 10.1093.
     PubMed     Abstract available
     
     
     
141. TAI DBG, Patel R, Lovecchio F, Kwee T, et al
     State-of-the-Art Review: Diagnosis and Management of Spinal Implant Infections.
     Clin Infect Dis. 2024;79:e65-e71.
     PubMed     Abstract available
     
     
     
142. LODISE TP, Bhavnani SM, Ambrose PG, Sader HS, et al
     Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing.
     Clin Infect Dis. 2024;79:1354-1362.
     PubMed     Abstract available
     
     
     
143. DAGAN R, van der Beek BA
     Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season.
     Clin Infect Dis. 2024 Dec 17:ciae619. doi: 10.1093.
     PubMed     Abstract available
     
     
     
144. AUMA E, Alberts R, Derendinger B, Venter R, et al
     Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibility.
     Clin Infect Dis. 2024 Dec 12:ciae614. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. KHAN U, Rich M, Franke M, Lachenal N, et al
     The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort.
     Clin Infect Dis. 2024 Dec 10:ciae601. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. ZHU Y, Forsman LD, Chen C, Zhang H, et al
     Reply to He et al: Established Association Between Glycemic Control and Anti-Tuberculosis Drug Exposures After Controlling Confounding Effects.
     Clin Infect Dis. 2024 Dec 9:ciae533. doi: 10.1093.
     PubMed    
     
     
     
147. CHEN J, Xie X, Zhang A, He Y, et al
     Is There a Genuine Correlation Between Blood Glucose Control and Anti-tuberculosis Drug Concentrations, or Is it Merely an Illusion?
     Clin Infect Dis. 2024 Dec 9:ciae532. doi: 10.1093.
     PubMed    
     
     
     November 2024
148. BUERGLER H, Gregoriano C, Laager R, Mueller B, et al
     Microbiological trends, in-hospital outcomes, and mortality in infective endocarditis: a Swiss-nationwide cohort study.
     Clin Infect Dis. 2024 Nov 27:ciae582. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. STAVROPOULOU E, Monney P, Tzimas G, Ianculescu N, et al
     Predictors of persistent fever among patients with suspected infective endocarditis: think outside the box.
     Clin Infect Dis. 2024 Nov 27:ciae588. doi: 10.1093.
     PubMed     Abstract available
     
     
     
150. BIRCK MG, Moura CS, Winthrop KL, Machado MAA, et al
     Choosing Wisely: Effectiveness and Safety of Antibiotic Prophylaxis in Close Contacts of Invasive Group A Streptococci Infection.
     Clin Infect Dis. 2024 Nov 26:ciae524. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. GASOYAN H, Deshpande A, Imrey PB, Guo N, et al
     Potential Implications of Using Locally Validated Risk Factors for Drug-Resistant Pathogens in Patients With Community-Acquired Pneumonia in US Hospitals: A Cross-Sectional Study.
     Clin Infect Dis. 2024;79:1277-1282.
     PubMed     Abstract available
     
     
     
152. JIMENEZ A, Rosa R, Ayoub S, Guran R, et al
     Factors Associated With Poor Clinical and Microbiologic Outcomes in Candida auris Bloodstream Infection: A Multicenter Retrospective Cohort Study.
     Clin Infect Dis. 2024;79:1262-1268.
     PubMed     Abstract available
     
     
     
153. RAY MJ, Strnad LC, Tucker KJ, Furuno JP, et al
     Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.
     Clin Infect Dis. 2024;79:1129-1135.
     PubMed     Abstract available
     
     
     
154. PUYAT JH, Brode SK, Shulha H, Romanowski K, et al
     Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data.
     Clin Infect Dis. 2024 Nov 20:ciae561. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. ROSEN LV, Thielking AM, Dugdale CM, Montepiedra G, et al
     Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks.
     Clin Infect Dis. 2024 Nov 15:ciae508. doi: 10.1093.
     PubMed     Abstract available
     
     
     
156. FERRAN E, Chan C, Sheikh N, Dedicoat M, et al
     Population-level frequency of fluoroquinolone resistance by whole-genome sequencing drug predictions in Mycobacterium tuberculosis complex isolates in England from 2017-2023.
     Clin Infect Dis. 2024 Nov 13:ciae560. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. PU J, Wu S, He JQ
     Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive Patients with Tuberculosis: a systematic review and meta-analysis of randomized controlled trials.
     Clin Infect Dis. 2024 Nov 11:ciae563. doi: 10.1093.
     PubMed     Abstract available
     
     
     
158. CRITCHLEY JA, Limb ES, Khakharia A, Carey IM, et al
     Tuberculosis and increased incidence of cardiovascular disease: Cohort study using US and UK health records.
     Clin Infect Dis. 2024 Nov 4:ciae538. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2024
159. BROOKS JT, Solans BP, Beranger A, Schaaf HS, et al
     Linezolid Pharmacokinetic-Anemia Modeling in Children with Rifampicin-Resistant Tuberculosis.
     Clin Infect Dis. 2024 Oct 18:ciae497. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. NGUYEN MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, et al
     Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.
     Clin Infect Dis. 2024;79:e27-e47.
     PubMed     Abstract available
     
     
     
161. NGUYEN MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, et al
     Executive Summary: State-of-the-Art Review: Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.
     Clin Infect Dis. 2024;79:805-806.
     PubMed    
     
     
     
162. WANG T, Park B, Anderson G, Shaller B, et al
     Application of Diagnostic Stewardship to Fungal Polymerase Chain Reaction: Low Yield of Follow-up Testing on Plasma and Bronchoalveolar Lavage After a Negative Result.
     Clin Infect Dis. 2024;79:944-952.
     PubMed     Abstract available
     
     
     
163. SELF WH, Johnson KD, Resser JJ, Whitney CG, et al
     Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022.
     Clin Infect Dis. 2024;79:838-847.
     PubMed     Abstract available
     
     
     
164. HORNE M, Woolley I, Lau JSY
     The Use of Long-term Antibiotics for Suppression of Bacterial Infections.
     Clin Infect Dis. 2024;79:848-854.
     PubMed     Abstract available
     
     
     
165. ONG SWX, Luo J, Fridman DJ, Lee SM, et al
     Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study.
     Clin Infect Dis. 2024;79:855-863.
     PubMed     Abstract available
     
     
     
166. AITKEN SL, Pierce VM, Pogue JM, Kline EG, et al
     The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?
     Clin Infect Dis. 2024;79:834-837.
     PubMed     Abstract available
     
     
     
167. NATHAVITHARANA RR, Pearl A, Biewer A, Young L, et al
     Effects of respiratory isolation for tuberculosis to reduce community-based transmission: a systematic review.
     Clin Infect Dis. 2024 Oct 14:ciae496. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. 
     Correction to: Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.
     Clin Infect Dis. 2024 Oct 10:ciae492. doi: 10.1093.
     PubMed    
     
     
     
169. LAMBERINK H, Huygens S, Aerts R, Lagrou K, et al
     Superiority trials in invasive aspergillosis: a harsh reality check with the IA-DUET (HOVON502) trial.
     Clin Infect Dis. 2024 Oct 8:ciae501. doi: 10.1093.
     PubMed     Abstract available
     
     
     
170. VIRDEE AK, Knudtzen FC, Llibre JM, Omland LH, et al
     Risk of tuberculosis after achieving HIV virological suppression on antiretroviral therapy: a Danish nationwide prospective cohort study.
     Clin Infect Dis. 2024 Oct 8:ciae499. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. PATAMATAMKUL S
     Implications of Undiagnosed Subclinical Cryptococcal Meningitis in Clinically Asymptomatic Low-Titer Cryptococcal Antigenemia Among PLWH: More Questions to Answer.
     Clin Infect Dis. 2024 Oct 8:ciae507. doi: 10.1093.
     PubMed    
     
     
     
172. YANG YC, Chen BS, Dong C, Wei JC, et al
     Correspondence to Otogenic Meningitis Surgery Outcome Study.
     Clin Infect Dis. 2024 Oct 7:ciae503. doi: 10.1093.
     PubMed    
     
     
     September 2024
173. WEN SCH, Harris PNA, Forde B, Permana B, et al
     Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes.
     Clin Infect Dis. 2024;79:734-743.
     PubMed     Abstract available
     
     
     
174. DUDOIGNON E, Chevret S, Tsague S, Hamane S, et al
     Risk Factors and Outcome Associated With Fungal Infections in Patients With Severe Burn Injury: 10-year Retrospective IFI-BURN Study.
     Clin Infect Dis. 2024;79:682-689.
     PubMed     Abstract available
     
     
     
175. SMITH DJ, Thompson GR 3rd, Baddley JW, Pappas PG, et al
     Clinical Testing Guidance for Histoplasmosis in Patients With Community-acquired Pneumonia for Primary and Urgent Care Providers: Commentary on Enzyme Immunoassay Histoplasma Antibody Testing.
     Clin Infect Dis. 2024;79:797-798.
     PubMed    
     
     
     
176. CHRISTENSON JC, Barros N, Kirkpatrick L, Schneider JG, et al
     Clinical Testing Guidance for Histoplasmosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care Providers: Role of Enzyme Immunoassay Histoplasma-Specific Immunoglobulin G and Immunoglobulin M Testing.
     Clin Infect Dis. 2024;79:797.
     PubMed    
     
     
     
177. MOURAD A, Nwafo N, Skalla L, Holland TL, et al
     Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized controlled trials.
     Clin Infect Dis. 2024 Sep 18:ciae476. doi: 10.1093.
     PubMed     Abstract available
     
     
     
178. PROSTY C, Lee TC, McDonald EG
     Is More Always Better? Rethinking Monotherapy for Enterococcus faecalis Infective Endocarditis.
     Clin Infect Dis. 2024 Sep 6:ciae458. doi: 10.1093.
     PubMed    
     
     
     
179. DANNEELS P, Hamel JF, Dubee V
     Adjunctive Therapy in Enterococcus faecalis Endocarditis Treatment: Maybe Less is Not Enough.
     Clin Infect Dis. 2024 Sep 6:ciae459. doi: 10.1093.
     PubMed    
     
     
     
180. SEIFERT M, Catanzaro DG, Gracia M, Hillery N, et al
     Prospective exploratory evaluation of Cepheid Xpert Mycobacterium tuberculosis host response cartridge: a focus on adolescents and young adults.
     Clin Infect Dis. 2024 Sep 5:ciae461. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2024
181. HO EC, Olson KE, Butler M, Birkholz M, et al
     Clinical impact of pleural fluid Streptococcus pneumoniae PCR testing in children with complicated pneumonia.
     Clin Infect Dis. 2024 Aug 29:ciae439. doi: 10.1093.
     PubMed     Abstract available
     
     
     
182. PADMAPRIYADARSINI C, Oswal VS, Jain CD, Mariappan MV, et al
     Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
     Clin Infect Dis. 2024 Aug 28:ciae388. doi: 10.1093.
     PubMed     Abstract available
     
     
     
183. BOSMAN S, Ayakaka I, Muhairwe J, Kamele M, et al
     Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
     Clin Infect Dis. 2024 Aug 27:ciae378. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. DINH A, McNally M, D'Anglejan E, Mamona Kilu C, et al
     Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.
     Clin Infect Dis. 2024 Aug 27:ciae395. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. GAKURU J, Kagimu E, Dai B, Okurut S, et al
     Implementation of single high-dose liposomal amphotericin B based induction therapy for treatment of HIV-associated cryptococcal meningitis in Uganda: a comparative prospective cohort study.
     Clin Infect Dis. 2024 Aug 24:ciae413. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. DONSKEY CJ, Dubberke ER, Klein NP, Liles EG, et al
     CLOVER: A Phase 3 Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection.
     Clin Infect Dis. 2024 Aug 24:ciae410. doi: 10.1093.
     PubMed     Abstract available
     
     
     
187. PERI AM, Chatfield MD, Ling W, Furuya-Kanamori L, et al
     Rapid Diagnostic Tests and Antimicrobial Stewardship Programs for the Management of Bloodstream Infection: What Is Their Relative Contribution to Improving Clinical Outcomes? A Systematic Review and Network Meta-analysis.
     Clin Infect Dis. 2024;79:502-515.
     PubMed     Abstract available
     
     
     
188. NARAYANAN N, Mathers AJ, Wenzler E, Moore NM, et al
     Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.
     Clin Infect Dis. 2024;79:516-523.
     PubMed     Abstract available
     
     
     
189. WINSTON DJ, Young PA, Schlamm HT, Schiller GJ, et al
     Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host.
     Clin Infect Dis. 2024;79:572.
     PubMed    
     
     
     
190. DUDOIGNON E, Camelena F, de Tymowski C, Lafaurie M, et al
     Shorter Versus Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia: Time for a Tailored Duration?
     Clin Infect Dis. 2024;79:577-579.
     PubMed    
     
     
     
191. JAYASINGHE S, Williams PCM, Macartney KK, Crawford NW, et al
     Assessing the Impact of Pneumococcal Conjugate Vaccine Immunization Schedule Change From 3+0 to 2+1 in Australian Children: A Retrospective Observational Study.
     Clin Infect Dis. 2024 Aug 14:ciae377. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. WONG A, Lima N, Applegate TL, Guy R, et al
     Viability of Chlamydia trachomatis in different anatomical sites - a systematic review & meta-analysis.
     Clin Infect Dis. 2024 Aug 5:ciae401. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2024
193. SCOTT P, Haranaka M, Choi JH, Stacey H, et al
     A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (Stride-6).
     Clin Infect Dis. 2024 Jul 31:ciae383. doi: 10.1093.
     PubMed     Abstract available
     
     
     
194. SERRIS A, Rautemaa-Richardson R, Laranjinha J, Candoni A, et al
     European Study of Cerebral Aspergillosis treated with Isavuconazole: an EFISG study.
     Clin Infect Dis. 2024 Jul 30:ciae371. doi: 10.1093.
     PubMed     Abstract available
     
     
     
195. MEYA DB, Nalintya E, Skipper CP, Kirumira P, et al
     Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With Human Immunodeficiency Virus (HIV)-Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen (CrAg) Titers.
     Clin Infect Dis. 2024 Jul 24:ciae266. doi: 10.1093.
     PubMed     Abstract available
     
     
     
196. PROSTY C, Sorin M, Katergi K, Khalaf R, et al
     Revisiting the Evidence Base Informing the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-Analysis.
     Clin Infect Dis. 2024 Jul 23:ciae379. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. KAUPPINEN KJ, Aho I, Sjoblom N, Tynninen O, et al
     Effect of Two Forms of Tenofovir on Duodenal Enterocytes - a Hypothesis for Different Effect of TDF and TAF on Body Weight and Plasma Lipids.
     Clin Infect Dis. 2024 Jul 23:ciae374. doi: 10.1093.
     PubMed     Abstract available
     
     
     
198. JARRETT BA, Shearer K, Motlhaoleng K, Chon S, et al
     Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With Human Immunodeficiency Virus in the North West Province of South Africa (the Teko Study): A Cl
     Clin Infect Dis. 2024 Jul 22:ciae268. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. BOUTIN CA, Durocher F, Beauchemin S, Ziegler D, et al
     Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review.
     Clin Infect Dis. 2024;79:151-160.
     PubMed     Abstract available
     
     
     
200. KINAMON T, Waack U, Needles M, Rubin D, et al
     Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs.
     Clin Infect Dis. 2024;79:60-69.
     PubMed     Abstract available
     
     
     
201. MAILLARD A, Dortet L, Delory T, Lafaurie M, et al
     Mutation Rate of AmpC beta-Lactamase-Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution.
     Clin Infect Dis. 2024;79:52-55.
     PubMed     Abstract available
     
     
     
202. TEMKIN E, Solter E, Lugassy C, Chen D, et al
     The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection.
     Clin Infect Dis. 2024;79:22-29.
     PubMed     Abstract available
     
     
     
203. GIANNELLA M, Pascale R, Viale P
     Progression From Carriage to Bloodstream Infection and Fatality by Different Enterobacterales Species, Carbapenemases, and Host Settings: Deciphering the Melting Pot.
     Clin Infect Dis. 2024;79:30-32.
     PubMed    
     
     
     
204. EUBANK TA, Dureja C, Garey KW, Hurdle JG, et al
     Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.
     Clin Infect Dis. 2024;79:15-21.
     PubMed     Abstract available
     
     
     
205. GROSSMAN MK, Rankin DA, Maloney M, Stanton RA, et al
     Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears.
     Clin Infect Dis. 2024;79:6-14.
     PubMed     Abstract available
     
     
     
206. FRATONI AJ, Gethers ML, Nicolau DP, Kuti JL, et al
     Non-KPC Attributes of Newer beta-lactam/beta-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa.
     Clin Infect Dis. 2024;79:33-42.
     PubMed     Abstract available
     
     
     
207. NUSSBAUM EZ, Koo S, Kotton CN
     Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study.
     Clin Infect Dis. 2024;79:208-214.
     PubMed     Abstract available
     
     
     
208. EDOSA M, Jeon Y, Gedefaw A, Hailu D, et al
     Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
     Clin Infect Dis. 2024;79.
     PubMed     Abstract available
     
     
     
209. WORKU DEMLIE Y, Gedefaw A, Jeon Y, Hailu D, et al
     Retrospective Analysis of Cholera/Acute Watery Diarrhea Outbreaks in Ethiopia From 2001 To 2023: Incidence, Case Fatality Rate, and Seasonal and Multiyear Epidemic Patterns.
     Clin Infect Dis. 2024;79.
     PubMed     Abstract available
     
     
     
210. HUSSEN M, Worku Demlie Y, Edosa M, Kebede M, et al
     Ethiopia National Cholera Elimination Plan 2022-2028: Experiences, Challenges, and the Way Forward.
     Clin Infect Dis. 2024;79.
     PubMed     Abstract available
     
     
     
211. HAILU D, Jeon Y, Gedefaw A, Kim JH, et al
     Dissecting Water, Sanitation, and Hygiene (WaSH) to Assess Risk Factors for Cholera in Shashemene, Oromia Region, Ethiopia.
     Clin Infect Dis. 2024;79.
     PubMed     Abstract available
     
     
     
212. GETAHUN T, Hailu D, Mogeni OD, Mesfin Getachew E, et al
     Healthcare Seeking Behavior and Disease Perception Toward Cholera and Acute Diarrhea Among Populations Living in Cholera High-Priority Hotspots in Shashemene, Ethiopia.
     Clin Infect Dis. 2024;79.
     PubMed     Abstract available
     
     
     
213. PARK SE, Gedefaw A, Hailu D, Jeon Y, et al
     Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.
     Clin Infect Dis. 2024;79.
     PubMed     Abstract available
     
     
     
214. PAPADIMITRIOU-OLIVGERIS M, Monney P, Frank M, Tzimas G, et al
     Comparison of the 2015 and 2023 European Society of Cardiology versions of the Duke criteria among patients with suspected infective endocarditis.
     Clin Infect Dis. 2024 Jul 12:ciae370. doi: 10.1093.
     PubMed     Abstract available
     
     
     
215. PRAKASH BABU S, Ezhumalai K, Raghupathy K, Karoly M, et al
     Factors associated with unfavourable treatment outcomes among persons with Pulmonary Tuberculosis: a multicentric prospective cohort study from India.
     Clin Infect Dis. 2024 Jul 11:ciae367. doi: 10.1093.
     PubMed     Abstract available
     
     
     
216. SORIANO A, Honore PM, Cornely OA, Chayakulkeeree M, et al
     Treatment Outcomes Among Patients With a Positive Candida Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study.
     Clin Infect Dis. 2024 Jul 10:ciae363. doi: 10.1093.
     PubMed     Abstract available
     
     
     
217. WANG MS, Li-Hunnam J, Chen YL, Gilmour B, et al
     Conversion or reversion of interferon gamma release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
     Clin Infect Dis. 2024 Jul 2:ciae357. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2024
218. KIMUDA S, Kwizera R, Dai B, Kigozi E, et al
     Comparison of early fungicidal activity and mortality between daily liposomal amphotericin B and daily amphotericin B deoxycholate among patients with HIV-associated cryptococcal meningitis.
     Clin Infect Dis. 2024 Jun 29:ciae326. doi: 10.1093.
     PubMed     Abstract available
     
     
     
219. SWETS MC, Bakk Z, Westgeest AC, Berry K, et al
     Clinical sub-phenotypes of Staphylococcus aureus bacteraemia.
     Clin Infect Dis. 2024 Jun 25:ciae338. doi: 10.1093.
     PubMed     Abstract available
     
     
     
220. ZHU Y, Forsman LD, Chen C, Zhang H, et al
     Drug exposure and treatment outcomes in patients with multidrug resistant tuberculosis and diabetes mellitus: A multicenter prospective cohort study from China.
     Clin Infect Dis. 2024 Jun 24:ciae329. doi: 10.1093.
     PubMed     Abstract available
     
     
     
221. ALONSO-MENCHEN D, Marin-Arriaza M, Villamarin M, Fernandez-Hidalgo N, et al
     Cutibacterium species valvular and cardiac device-related infective endocarditis: contemporary data from the GAMES prospective cohort (2008-2023).
     Clin Infect Dis. 2024 Jun 24:ciae334. doi: 10.1093.
     PubMed     Abstract available
     
     
     
222. RICHTERMAN A, Saintilien E, St-Cyr M, Claudia Gracia L, et al
     Food Insecurity at Tuberculosis Treatment Initiation Is Associated With Clinical Outcomes in Rural Haiti: A Prospective Cohort Study.
     Clin Infect Dis. 2024 Jun 18:ciae252. doi: 10.1093.
     PubMed     Abstract available
     
     
     
223. KWAK N, Henkle E, Hwang H, Jeon D, et al
     Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort.
     Clin Infect Dis. 2024;78:1690-1697.
     PubMed     Abstract available
     
     
     
224. OLADAPO-SHITTU O, Cosgrove SE, Rock C, Hsu YJ, et al
     Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study.
     Clin Infect Dis. 2024;78:1632-1639.
     PubMed     Abstract available
     
     
     
225. ANKRAH PK, Bock A, Ruffin F, Hanson BM, et al
     Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species.
     Clin Infect Dis. 2024;78:1458-1461.
     PubMed     Abstract available
     
     
     
226. HARDY M, Harris PNA, Paterson DL, Chatfield MD, et al
     Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.
     Clin Infect Dis. 2024;78:1482-1489.
     PubMed     Abstract available
     
     
     
227. OKHUYSEN PC, Ramesh MS, Louie T, Kiknadze N, et al
     A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.
     Clin Infect Dis. 2024;78:1462-1472.
     PubMed     Abstract available
     
     
     
228. SENCHYNA F, Murugesan K, Rotunno W, Nadimpalli SS, et al
     Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection.
     Clin Infect Dis. 2024;78:1425-1428.
     PubMed     Abstract available
     
     
     
229. MORQUIN D, Lejeune J, Agostini C, Godreuil S, et al
     Time Is of the Essence: Achieving Prompt and Effective Antimicrobial Therapy of Bloodstream Infection With Advanced Hospital Information Systems.
     Clin Infect Dis. 2024;78:1434-1442.
     PubMed     Abstract available
     
     
     
230. JJINGO CJ, Bala S, Waack U, Needles M, et al
     Food and Drug Administration Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.
     Clin Infect Dis. 2024;78:1564-1570.
     PubMed     Abstract available
     
     
     
231. SMITH DJ, Free RJ, Thompson GR 3rd, Baddley JW, et al
     Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care Providers.
     Clin Infect Dis. 2024;78:1559-1563.
     PubMed     Abstract available
     
     
     
232. BROWN L, Rautemaa-Richardson R, Mengoli C, Alanio A, et al
     Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis.
     Clin Infect Dis. 2024 Jun 11:ciae239. doi: 10.1093.
     PubMed     Abstract available
     
     
     
233. COOPER LN, Beauchamp AM, Ingle TA, Diaz MI, et al
     Socioeconomic Disparities and the Prevalence of Antimicrobial Resistance.
     Clin Infect Dis. 2024 Jun 7:ciae313. doi: 10.1093.
     PubMed     Abstract available
     
     
     
234. FOURRE N, Zimmermann V, Senn L, Monney P, et al
     Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia.
     Clin Infect Dis. 2024 Jun 6:ciae315. doi: 10.1093.
     PubMed     Abstract available
     
     
     
235. DEQUIDT T, Boutellis J, Coussement J
     Relationship between appropriateness of empirical antibiotic therapy and mortality in patients with streptococcal bloodstream infection.
     Clin Infect Dis. 2024 Jun 6:ciae312. doi: 10.1093.
     PubMed    
     
     
     
236. FOURRE N, Guery B, Papadimitriou-Olivgeris M
     Factors contributing to delayed initiation of appropriate antimicrobial treatment in patients with streptococcal bacteremia.
     Clin Infect Dis. 2024 Jun 6:ciae317. doi: 10.1093.
     PubMed    
     
     
     
237. TESHOME BF, Park T, Arackal J, Hampton N, et al
     Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study.
     Clin Infect Dis. 2024 Jun 6:ciae253. doi: 10.1093.
     PubMed     Abstract available
     
     
     
238. RASHITOV M, Franke M, Trevisi L, Bekbolatova G, et al
     Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
     Clin Infect Dis. 2024 Jun 4:ciae305. doi: 10.1093.
     PubMed     Abstract available
     
     
     
239. ABBOTT R, Landsiedel K, Atukunda M, Puryear SB, et al
     Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda.
     Clin Infect Dis. 2024 Jun 2:ciae304. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2024
240. ANPALAGAN K, Dotel R, MacFadden DR, Smith S, et al
     Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial.
     Clin Infect Dis. 2024 May 27:ciae289. doi: 10.1093.
     PubMed     Abstract available
     
     
     
241. RUSSELL CD, Berry K, Cooper G, Sim W, et al
     Distinct clinical endpoints of Staphylococcus aureus bacteraemia complicate assessment of outcome.
     Clin Infect Dis. 2024 May 20:ciae281. doi: 10.1093.
     PubMed     Abstract available
     
     
     
242. PINEDA-REYES R, Neil BH, Orndorff J, Williams-Bouyer N, et al
     Clinical presentation, antimicrobial resistance, and treatment outcomes of Aeromonas human infections: A 14-year retrospective study and comparative genomics of two isolates from fatal cases.
     Clin Infect Dis. 2024 May 17:ciae272. doi: 10.1093.
     PubMed     Abstract available
     
     
     
243. GETANDA P, Jagne I, Bognini JD, Camara B, et al
     Impact of Intrapartum Azithromycin on the Carriage and Antibiotic Resistance of Escherichia coli and Klebsiella pneumoniae in Mothers and their Newborns: a sub-study of a Randomized Double-Blind Trial Conducted in The Gambia and Burkina Faso.
     Clin Infect Dis. 2024 May 16:ciae280. doi: 10.1093.
     PubMed     Abstract available
     
     
     
244. BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
     Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
     Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
     PubMed     Abstract available
     
     
     
245. HAMILL MM, Ghanem KG, Tuddenham S
     Executive Summary: State-of-the-Art Review: Neurosyphilis.
     Clin Infect Dis. 2024;78:1085-1087.
     PubMed    
     
     
     
246. PLYMOTH M, Lundqvist R, Nystedt A, Sjostedt A, et al
     Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
     Clin Infect Dis. 2024;78:1222-1231.
     PubMed     Abstract available
     
     
     
247. FALCONE M, Giordano C, Leonildi A, Galfo V, et al
     Clinical Features and Outcomes of Infections Caused by Metallo-beta-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area.
     Clin Infect Dis. 2024;78:1111-1119.
     PubMed     Abstract available
     
     
     
248. HAREZA DA, Cosgrove SE, Simner PJ, Harris AD, et al
     Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum beta-Lactamase-Producing Enterobacterales Bloodstream Infections?
     Clin Infect Dis. 2024;78:1103-1110.
     PubMed     Abstract available
     
     
     
249. CORTES-PENFIELD NW, Musher DM
     Give Penicillin or Ceftriaxone: Neurosyphilis Does Not Deal in Absolutes.
     Clin Infect Dis. 2024;78:1386-1387.
     PubMed    
     
     
     
250. XIE L, Li W, Ye WM, Xiao Y, et al
     Enhancing Neurosyphilis Diagnosis: Evaluating Novel Biomarkers and Clinical Implementation Challenges.
     Clin Infect Dis. 2024;78:1385-1386.
     PubMed    
     
     
     
251. ITO H
     Enhancing Neurosyphilis Diagnosis: Evaluating Serum Biomarkers as Non-Invasive Alternatives to Lumbar Puncture.
     Clin Infect Dis. 2024;78:1384-1385.
     PubMed    
     
     
     
252. HAMILL MM, Ghanem KG, Tuddenham S
     State-of-the-Art Review: Neurosyphilis.
     Clin Infect Dis. 2024;78:e57-e68.
     PubMed     Abstract available
     
     
     
253. SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
     Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
     Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
     PubMed     Abstract available
     
     
     
254. DANIELS E, Atkinson A, Cardoza N, Ramakrishnan A, et al
     Social Factors Associated with Congenital Syphilis in Missouri.
     Clin Infect Dis. 2024 May 12:ciae260. doi: 10.1093.
     PubMed     Abstract available
     
     
     
255. LAMAS C
     Correspondence on the validation of the Duke-ISCVID criteria for the diagnosis of infective endocarditis: what of the new major microbiological criteria?
     Clin Infect Dis. 2024 May 3:ciae217. doi: 10.1093.
     PubMed    
     
     
     April 2024
256. SRIVATHSAN A, Abdou A, Al-Khatib T, Apadinuwe SC, et al
     District-Level Forecast of Achieving Trachoma Elimination as a Public Health Problem By 2030: An Ensemble Modelling Approach.
     Clin Infect Dis. 2024;78.
     PubMed     Abstract available
     
     
     
257. SUNNERHAGEN T, Rasmussen M
     Lower specificity of the ESC2023 diagnostic criteria for infective endocarditis when spondylodiscitis is regarded as a vascular phenomenon.
     Clin Infect Dis. 2024 Apr 24:ciae223. doi: 10.1093.
     PubMed     Abstract available
     
     
     
258. RANZENIGO M, van Soest TM, Hensen EF, Cinque P, et al
     Otitis in patients with Community-Acquired Bacterial Meningitis: A Nationwide Prospective Cohort Study.
     Clin Infect Dis. 2024 Apr 24:ciae221. doi: 10.1093.
     PubMed     Abstract available
     
     
     
259. OLDBERG K, Rasmussen M
     Make modern microbiology matter more in the 2023 ESC guidelines for the management of infective endocarditis.
     Clin Infect Dis. 2024 Apr 24:ciae222. doi: 10.1093.
     PubMed     Abstract available
     
     
     
260. SINHA P, Ezhumalai K, Du X, Ponnuraja C, et al
     Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis.
     Clin Infect Dis. 2024 Apr 23:ciae149. doi: 10.1093.
     PubMed     Abstract available
     
     
     
261. FIGGATT MC, Rosen DL, Chu VH, Wu LT, et al
     Long-term risk of serious infections and mortality among patients surviving drug use-associated infective endocarditis.
     Clin Infect Dis. 2024 Apr 20:ciae214. doi: 10.1093.
     PubMed     Abstract available
     
     
     
262. SHRESTHA NK, Kanyo EC, Nakhoul GN, Herlitz LC, et al
     Association between Causative Pathogen and Occurrence of Infection-Related Glomerulonephritis in Infective Endocarditis.
     Clin Infect Dis. 2024 Apr 18:ciae213. doi: 10.1093.
     PubMed     Abstract available
     
     
     
263. FARHAT MR, Jacobson KR
     For Tuberculosis, Not "To Screen or Not to Screen?" but "Who?" and "How?".
     Clin Infect Dis. 2024 Apr 18:ciae058. doi: 10.1093.
     PubMed     Abstract available
     
     
     
264. GOSWAMI N, Reed C
     Duration of Effective Tuberculosis Treatment, not Acid-Fast Bacilli (AFB) Smear Status, as the Determinant for Deisolation in Community Settings.
     Clin Infect Dis. 2024 Apr 18:ciae198. doi: 10.1093.
     PubMed    
     
     
     
265. SHAH M, Dansky Z, Nathavitharana R, Behm H, et al
     NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings.
     Clin Infect Dis. 2024 Apr 18:ciae199. doi: 10.1093.
     PubMed    
     
     
     
266. TAMMA PD, Immel S, Karaba SM, Soto CL, et al
     Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis with Sulbactam-Durlobactam.
     Clin Infect Dis. 2024 Apr 17:ciae210. doi: 10.1093.
     PubMed     Abstract available
     
     
     
267. RUBIS AB, Cole M, Tondella ML, Pawloski LC, et al
     Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.
     Clin Infect Dis. 2024 Apr 12:ciae207. doi: 10.1093.
     PubMed     Abstract available
     
     
     
268. CHASTAIN DB, Spradlin M, Ahmad H, Henao-Martinez AF, et al
     Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.
     Clin Infect Dis. 2024;78:811-812.
     PubMed    
     
     
     
269. MARINER-LLICER C, Saavedra Cervera B, Mambuque E, Gomes N, et al
     Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
     Clin Infect Dis. 2024;78:842-845.
     PubMed     Abstract available
     
     
     
270. MIKIASHVILI L, Kempker RR, Chakhaia TS, Bablishvili N, et al
     Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
     Clin Infect Dis. 2024;78:1043-1052.
     PubMed     Abstract available
     
     
     
271. UJIIE M
     Tetanus Toxoid Antibody Seroprevalence in Japan.
     Clin Infect Dis. 2024;78:1079-1080.
     PubMed    
     
     
     
272. QIU J, Zimmet AN, Bell TD, Gadrey S, et al
     Pathophysiological Responses to Bloodstream Infection in Critically Ill Transplant Recipients Compared With Non-Transplant Recipients.
     Clin Infect Dis. 2024;78:1011-1021.
     PubMed     Abstract available
     
     
     
273. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
     Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
     Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
     PubMed     Abstract available
     
     
     
274. HENDRIKS MMC, Schweren KSA, Kleij A, Berrevoets MAH, et al
     Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: A multicenter retrospective cohort study.
     Clin Infect Dis. 2024 Apr 5:ciae187. doi: 10.1093.
     PubMed     Abstract available
     
     
     
275. SHIELDS RK, Cheng WY, Kponee-Shovein K, Indacochea D, et al
     Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli-Causing Uncomplicated Urinary Tract Infection.
     Clin Infect Dis. 2024 Apr 4:ciae171. doi: 10.1093.
     PubMed     Abstract available
     
     
     
276. RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
     Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
     Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2024
277. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
     Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
     Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
     PubMed     Abstract available
     
     
     
278. FOURRE N, Zimmermann V, Senn L, Aruanno M, et al
     Predictors of mortality of streptococcal bacteremia and the role of infectious diseases consultation; a retrospective cohort study.
     Clin Infect Dis. 2024 Mar 25:ciae168. doi: 10.1093.
     PubMed     Abstract available
     
     
     
279. MORGAN H, Ndjeka N, Hasan T, Gegia M, et al
     Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study.
     Clin Infect Dis. 2024 Mar 25:ciae145. doi: 10.1093.
     PubMed     Abstract available
     
     
     
280. SAKOULAS G, Tsou EE, Geriak M, Vasina L, et al
     Contemporary Management of Staphylococcus aureus Bacteremia: Some Additional Considerations for Clinicians.
     Clin Infect Dis. 2024 Mar 20:ciae080. doi: 10.1093.
     PubMed    
     
     
     
281. SUNSTRUM J, Power LE, Fligiel HM, Lauter C, et al
     Human Disease due to Mycobacterium bovis Linked to Free-Ranging Deer in Michigan.
     Clin Infect Dis. 2024;78:637-645.
     PubMed     Abstract available
     
     
     
282. BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al
     Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
     Clin Infect Dis. 2024;78:554-561.
     PubMed     Abstract available
     
     
     
283. KRISHNAN S, Chaisson RE
     US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
     Clin Infect Dis. 2024;78:514-517.
     PubMed     Abstract available
     
     
     
284. FRANCOIS WATKINS LK, Luna S, Bruce BB, Medalla F, et al
     Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance-Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004-2018.
     Clin Infect Dis. 2024;78:535-543.
     PubMed     Abstract available
     
     
     
285. FENG X, Qian C, Fan Y, Li J, et al
     Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
     Clin Infect Dis. 2024;78:518-525.
     PubMed     Abstract available
     
     
     
286. MUTHU V, Agarwal R
     Pulmonary Artery Aneurysms: Mycotic or Mycobacterial?
     Clin Infect Dis. 2024;78:805-806.
     PubMed    
     
     
     
287. MOHANTY S, Ye G, Sheets C, Cossrow N, et al
     Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults.
     Clin Infect Dis. 2024 Mar 14:ciae138. doi: 10.1093.
     PubMed     Abstract available
     
     
     
288. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
     The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia.
     Clin Infect Dis. 2024 Mar 11:ciae126. doi: 10.1093.
     PubMed    
     
     
     
289. MEMBRILLO DE NOVALES FJ, Bravo de Pablo O, Estella Garcia A, Morata Ruiz L, et al
     The positioning of ceftobiprole in Staphylococcus aureus bacteremia.
     Clin Infect Dis. 2024 Mar 11:ciae123. doi: 10.1093.
     PubMed    
     
     
     
290. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
     Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
     Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
     PubMed     Abstract available
     
     
     
291. TANNOUS E, Lipman-Arens S, Cohen R
     Should a minimum Daptomycin AUC24h of 666 mg/L/h be the target in Staphylococcus aureus infections?
     Clin Infect Dis. 2024 Mar 6:ciae086. doi: 10.1093.
     PubMed    
     
     
     February 2024
292. CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
     Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
     Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.
     PubMed    
     
     
     
293. BRADLEY JS, Bulitta JB, Cook R, Yu PA, et al
     Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.
     Clin Infect Dis. 2024 Feb 27:ciae093. doi: 10.1093.
     PubMed     Abstract available
     
     
     
294. TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
     Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
     Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
     PubMed     Abstract available
     
     
     
295. STEADMAN A, Andama A, Ball A, Mukwatamundu J, et al
     New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.
     Clin Infect Dis. 2024 Feb 2:ciae041. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2024
296. BONOMO RA, Perez F, Hujer AM, Hujer KM, et al
     The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond.
     Clin Infect Dis. 2024 Jan 30:ciad758. doi: 10.1093.
     PubMed    
     
     
     
297. FENG X, Qian C, Fan Y, Li J, et al
     The Necessity of Studying Antibiotic Duration in Acute Leukemia Patients With Pseudomonas aeruginosa Bloodstream Infection: A Response to Terada and Kanno.
     Clin Infect Dis. 2024 Jan 17:ciae013. doi: 10.1093.
     PubMed    
     
     
     
298. MATSUO T, Wurster S, Kontoyiannis DP
     Good Outcomes in Salvage Therapy of Fusariosis in Patients With Leukemia: Is It the Host or the Drug?
     Clin Infect Dis. 2024 Jan 4:ciad768. doi: 10.1093.
     PubMed    
     
     
     December 2023
299. RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
     Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
     Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
     PubMed     Abstract available
     
     
     
300. DOUD MB, Haste NM, Abeles SR
     Correspondence to Hasegawa et al. "Diagnostic Accuracy of Hospital Antibiograms in Predicting the Risk of Antimicrobial Resistance in Enterobacteriaceae Isolates: A Nationwide Multicenter Evaluation at the Veterans Health Administration".
     Clin Infect Dis. 2023 Dec 6:ciad748. doi: 10.1093.
     PubMed    
     
     
     November 2023
301. BOULWARE DR
     When Someone Should Do Something About This: How a Cryptococcal Clinical Trialist Became Involved With the Coronavirus Disease 2019 Pandemic.
     Clin Infect Dis. 2023 Nov 16:ciad648. doi: 10.1093.
     PubMed    
     
     
     October 2023
302. STRAUB TJ, Lombardo MJ, Bryant JA, Diao L, et al
     Impact of a purified microbiome therapeutic on abundance of antimicrobial resistance genes in patients with recurrent Clostridioides difficile infection.
     Clin Infect Dis. 2023 Oct 12:ciad636. doi: 10.1093.
     PubMed     Abstract available
     
     
     
303. YANG E, Sajhwani D, Fassnacht R, Mehta L, et al
     High rates of acquisition of toxigenic Clostridioides difficile colonization without subsequent infection during acute lymphoblastic leukemia treatment in children.
     Clin Infect Dis. 2023 Oct 11:ciad628. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.